Funding
The authors have no grants or financial support to report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
D.S. reports funding from Speakers Bureau (Incyte, Genentech). Institutional funding was received from Amgen, Apexigen, Bristol-Myers Squibb, Celgene, FibroGen, Genentech, Medimmune, Merck, OncoMed, and Rafael.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Turner, K.M., Delman, A.M., Vaysburg, D.M. et al. ASO Visual Abstract: Systemic Therapy for Resected Pancreatic Adenocarcinoma—How Much Is Enough?. Ann Surg Oncol 29, 3475–3476 (2022). https://doi.org/10.1245/s10434-022-11421-7
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11421-7